O	O	O	0	3	Non	Non	B-NP	AFX	B-protein	7	NMOD	B-protein
O	O	O	3	4	-	-	I-NP	HYPH	B-DNA	7	NMOD	B-DNA
O	O	O	4	13	steroidal	steroidal	I-NP	JJ	I-DNA	7	NMOD	I-DNA
O	O	O	14	18	anti	anti	I-NP	AFX	I-DNA	7	NMOD	I-DNA
O	O	O	18	19	-	-	I-NP	HYPH	O	7	NMOD	O
O	O	O	19	31	inflammatory	inflammatory	I-NP	JJ	O	7	NMOD	O
O	O	O	32	37	drugs	drug	I-NP	NNS	O	8	SUB	O
O	O	O	38	45	inhibit	inhibit	B-VP	VBP	O	0	ROOT	O
O	O	O	46	49	the	the	B-NP	DT	O	10	NMOD	O
O	O	O	50	60	expression	expression	I-NP	NN	O	8	OBJ	O
O	O	O	61	63	of	of	B-PP	IN	O	10	NMOD	O
O	O	O	64	73	cytokines	cytokine	B-NP	NNS	B-protein	11	PMOD	B-protein
O	O	O	74	77	and	and	O	CC	O	8	VMOD	O
O	O	O	78	84	induce	induce	B-VP	VB	O	8	VMOD	O
O	O	O	85	90	HSP70	HSP70	B-NP	NN	B-protein	14	OBJ	B-protein
O	O	O	91	93	in	in	B-PP	IN	O	14	VMOD	O
O	O	O	94	99	human	human	B-NP	JJ	B-cell_type	18	NMOD	B-cell_type
O	O	O	100	109	monocytes	monocyte	I-NP	NNS	I-cell_type	16	PMOD	I-cell_type
O	O	O	109	110	.	.	O	.	O	8	P	O

O	O	O	112	118	Recent	Recent	B-NP	JJ	O	2	NMOD	O
O	O	O	119	126	studies	study	I-NP	NNS	O	3	SUB	O
O	O	O	127	131	have	have	B-VP	VBP	O	0	ROOT	O
O	O	O	132	137	shown	show	I-VP	VBN	O	3	VC	O
O	O	O	138	142	that	that	B-SBAR	IN	O	4	VMOD	O
O	O	O	143	146	the	the	B-NP	DT	O	13	NMOD	O
O	O	O	147	150	non	non	I-NP	AFX	O	13	NMOD	O
O	O	O	150	151	-	-	I-NP	HYPH	B-DNA	13	NMOD	B-DNA
O	O	O	151	160	steroidal	steroidal	I-NP	JJ	I-DNA	13	NMOD	I-DNA
O	O	O	161	165	anti	anti	I-NP	AFX	I-DNA	13	NMOD	I-DNA
O	O	O	165	166	-	-	I-NP	HYPH	O	13	NMOD	O
O	O	O	166	178	inflammatory	inflammatory	I-NP	JJ	O	13	NMOD	O
O	O	O	179	184	drugs	drug	I-NP	NNS	O	17	SUB	O
O	O	O	185	186	(	(	O	(	O	16	DEP	O
O	O	O	186	192	NSAIDs	NSAID	B-NP	NNS	O	16	DEP	O
O	O	O	192	193	)	)	O	)	O	13	NMOD	O
O	O	O	194	202	activate	activate	B-VP	VBP	O	5	SBAR	O
O	O	O	203	207	heat	heat	B-NP	NN	B-protein	21	NMOD	B-protein
O	O	O	208	213	shock	shock	I-NP	NN	I-protein	21	NMOD	I-protein
O	O	O	214	227	transcription	transcription	I-NP	NN	I-protein	21	NMOD	I-protein
O	O	O	228	234	factor	factor	I-NP	NN	I-protein	17	OBJ	I-protein
O	O	O	235	236	(	(	O	(	O	24	DEP	O
T1	B-Protein	B-Protein	236	240	HSF1	HSF1	B-NP	NN	B-protein	24	DEP	B-protein
O	O	O	240	241	)	)	O	)	O	21	NMOD	O
O	O	O	242	246	from	from	B-PP	IN	O	17	VMOD	O
O	O	O	247	248	a	a	B-NP	DT	O	29	NMOD	O
O	O	O	249	255	latent	latent	I-NP	JJ	B-protein	29	NMOD	B-protein
O	O	O	256	267	cytoplasmic	cytoplasmic	I-NP	JJ	I-protein	29	NMOD	I-protein
O	O	O	268	272	form	form	I-NP	NN	I-protein	25	PMOD	I-protein
O	O	O	273	275	to	to	B-PP	TO	O	25	PMOD	O
O	O	O	276	277	a	a	B-NP	DT	O	36	NMOD	O
O	O	O	278	285	nuclear	nuclear	I-NP	JJ	O	36	NMOD	O
O	O	O	285	286	,	,	I-NP	,	O	36	P	O
T22	B-Entity	B-Entity	287	290	DNA	DNA	I-NP	NN	O	36	NMOD	O
O	O	O	291	298	binding	binding	I-NP	NN	O	36	NMOD	O
O	O	O	299	304	state	state	I-NP	NN	O	30	PMOD	O
O	O	O	304	305	.	.	O	.	O	3	P	O

O	O	O	306	308	As	As	B-SBAR	IN	O	31	VMOD	O
T2	B-Protein	B-Protein	309	313	HSF1	HSF1	B-NP	NN	B-protein	3	SUB	B-protein
O	O	O	314	317	can	can	B-VP	MD	O	1	SBAR	O
O	O	O	318	326	function	function	I-VP	VB	O	3	VC	O
O	O	O	327	329	as	as	B-SBAR	IN	O	4	VMOD	O
O	O	O	330	334	both	both	O	CC	O	15	NMOD	O
O	O	O	335	337	an	an	B-NP	DT	O	8	NMOD	O
O	O	O	338	347	activator	activator	I-NP	NN	O	15	NMOD	O
O	O	O	348	350	of	of	B-PP	IN	O	8	NMOD	O
T23	B-Entity	B-Entity	351	355	heat	heat	B-NP	NN	B-DNA	12	NMOD	B-DNA
T23	I-Entity	I-Entity	356	361	shock	shock	I-NP	NN	I-DNA	12	NMOD	I-DNA
T23	I-Entity	I-Entity	362	367	genes	gene	I-NP	NNS	I-DNA	9	PMOD	I-DNA
O	O	O	368	371	and	and	O	CC	O	15	NMOD	O
O	O	O	372	373	a	a	B-NP	DT	O	15	NMOD	O
O	O	O	374	383	repressor	repressor	I-NP	NN	O	5	PMOD	O
O	O	O	384	386	of	of	B-PP	IN	O	15	NMOD	O
T24	B-Entity	B-Entity	387	390	non	non	B-NP	AFX	O	21	NMOD	O
T24	I-Entity	I-Entity	390	391	-	-	I-NP	HYPH	B-DNA	21	NMOD	B-DNA
T24	I-Entity	I-Entity	391	395	heat	heat	I-NP	NN	I-DNA	21	NMOD	I-DNA
T24	I-Entity	I-Entity	396	401	shock	shock	I-NP	NN	I-DNA	21	NMOD	I-DNA
T24	I-Entity	I-Entity	402	407	genes	gene	I-NP	NNS	I-DNA	16	PMOD	I-DNA
O	O	O	408	412	such	such	B-PP	JJ	O	23	PMOD	O
O	O	O	413	415	as	as	I-PP	IN	O	21	NMOD	O
T3	B-Protein	B-Protein	416	420	IL1B	IL1B	B-NP	NN	B-protein	28	NMOD	B-protein
O	O	O	421	424	and	and	I-NP	CC	O	28	NMOD	O
T4	B-Protein	B-Protein	425	426	c	c	I-NP	NN	B-DNA	28	NMOD	B-DNA
T4	I-Protein	I-Protein	426	427	-	-	O	HYPH	I-DNA	28	P	I-DNA
T4	I-Protein	I-Protein	428	431	fos	fos	B-NP	NN	I-DNA	23	PMOD	I-DNA
O	O	O	431	432	,	,	O	,	O	31	P	O
O	O	O	433	435	we	we	B-NP	PRP	O	31	SUB	O
O	O	O	436	440	have	have	B-VP	VBP	O	0	ROOT	O
O	O	O	441	449	examined	examine	I-VP	VBN	O	31	VC	O
O	O	O	450	453	the	the	B-NP	DT	O	35	NMOD	O
O	O	O	454	463	potential	potential	I-NP	JJ	O	35	NMOD	O
O	O	O	464	468	role	role	I-NP	NN	O	32	OBJ	O
O	O	O	469	471	of	of	B-PP	IN	O	35	NMOD	O
T5	B-Protein	B-Protein	472	476	HSF1	HSF1	B-NP	NN	B-protein	36	PMOD	B-protein
O	O	O	477	479	in	in	B-PP	IN	O	35	NMOD	O
O	O	O	480	483	the	the	B-NP	DT	O	40	NMOD	O
O	O	O	484	491	effects	effect	I-NP	NNS	O	38	PMOD	O
O	O	O	492	494	of	of	B-PP	IN	O	40	NMOD	O
O	O	O	495	501	NSAIDs	NSAID	B-NP	NNS	O	41	PMOD	O
O	O	O	502	504	on	on	B-PP	IN	O	40	NMOD	O
O	O	O	505	509	gene	gene	B-NP	NN	O	45	NMOD	O
O	O	O	510	520	expression	expression	I-NP	NN	O	43	PMOD	O
O	O	O	521	523	in	in	B-PP	IN	O	45	NMOD	O
O	O	O	524	525	a	a	B-NP	DT	O	52	NMOD	O
O	O	O	526	531	human	human	I-NP	JJ	B-cell_line	51	NMOD	B-cell_line
O	O	O	532	541	monocytic	monocytic	I-NP	JJ	I-cell_line	51	NMOD	I-cell_line
O	O	O	542	546	cell	cell	I-NP	NN	I-cell_line	51	NMOD	I-cell_line
O	O	O	547	551	line	line	I-NP	NN	I-cell_line	52	NMOD	I-cell_line
O	O	O	552	555	THP	THP	I-NP	NN	O	54	NMOD	O
O	O	O	555	556	-	-	B-NP	HYPH	O	54	P	O
O	O	O	556	557	1	1	I-NP	CD	O	46	PMOD	O
O	O	O	557	558	.	.	O	.	O	31	P	O

O	O	O	559	561	We	We	B-NP	PRP	O	2	SUB	O
O	O	O	562	567	found	find	B-VP	VBD	O	0	ROOT	O
O	O	O	568	572	that	that	B-SBAR	IN	O	2	VMOD	O
O	O	O	573	576	two	two	B-NP	CD	O	5	NMOD	O
O	O	O	577	584	members	member	I-NP	NNS	O	13	NMOD	O
O	O	O	585	587	of	of	B-PP	IN	O	5	NMOD	O
O	O	O	588	591	the	the	B-NP	DT	O	8	NMOD	O
O	O	O	592	598	NSAIDs	NSAID	I-NP	NNS	O	6	PMOD	O
O	O	O	598	599	,	,	O	,	O	13	P	O
O	O	O	600	606	sodium	sodium	B-NP	NN	O	11	NMOD	O
O	O	O	607	617	salicylate	salicylate	I-NP	NN	O	13	NMOD	O
O	O	O	618	621	and	and	I-NP	CC	O	13	NMOD	O
O	O	O	622	630	sulindac	sulindac	I-NP	NN	O	14	SUB	O
O	O	O	631	638	repress	repress	B-VP	VBP	O	3	SBAR	O
O	O	O	639	642	the	the	B-NP	DT	O	17	NMOD	O
T6	B-Protein	B-Protein	643	647	IL1B	IL1B	I-NP	NN	B-DNA	17	NMOD	B-DNA
T25	B-Entity	B-Entity	648	656	promoter	promoter	I-NP	NN	I-DNA	14	OBJ	I-DNA
O	O	O	657	659	to	to	B-PP	TO	O	14	VMOD	O
O	O	O	660	667	similar	similar	B-NP	JJ	O	20	NMOD	O
O	O	O	668	674	degree	degree	I-NP	NN	O	18	PMOD	O
O	O	O	675	677	to	to	B-PP	TO	O	20	NMOD	O
O	O	O	678	682	heat	heat	B-NP	NN	O	23	NMOD	O
O	O	O	683	688	shock	shock	I-NP	NN	O	26	NMOD	O
O	O	O	689	691	or	or	O	CC	O	26	NMOD	O
T7	B-Protein	B-Protein	692	696	HSF1	HSF1	B-NP	NN	B-protein	26	NMOD	B-protein
O	O	O	697	711	overexpression	overexpression	I-NP	NN	O	21	PMOD	O
O	O	O	711	712	.	.	O	.	O	2	P	O

O	O	O	713	715	In	In	B-PP	IN	O	16	VMOD	O
O	O	O	716	724	addition	addition	B-NP	NN	O	1	PMOD	O
O	O	O	724	725	,	,	O	,	O	16	P	O
O	O	O	726	732	sodium	sodium	B-NP	NN	O	5	NMOD	O
O	O	O	733	743	salicylate	salicylate	I-NP	NN	O	8	NMOD	O
O	O	O	744	747	and	and	O	CC	O	8	NMOD	O
O	O	O	748	758	additional	additional	B-NP	JJ	O	8	NMOD	O
O	O	O	759	765	NSAIDs	NSAID	I-NP	NNS	O	16	SUB	O
O	O	O	766	770	used	use	B-VP	VBN	O	8	NMOD	O
O	O	O	771	773	at	at	B-PP	IN	O	9	VMOD	O
O	O	O	774	788	concentrations	concentration	B-NP	NNS	O	10	PMOD	O
O	O	O	789	793	that	that	B-NP	WDT	O	11	NMOD	O
O	O	O	794	802	activate	activate	B-VP	VBP	O	12	SBAR	O
T8	B-Protein	B-Protein	803	807	HSF1	HSF1	B-NP	NN	B-protein	13	OBJ	B-protein
O	O	O	808	812	also	also	B-ADVP	RB	O	16	VMOD	O
O	O	O	813	822	inhibited	inhibit	B-VP	VBD	O	0	ROOT	O
O	O	O	823	826	the	the	B-NP	DT	O	18	NMOD	O
O	O	O	827	837	expression	expression	I-NP	NN	O	16	OBJ	O
O	O	O	838	840	of	of	B-PP	IN	O	18	NMOD	O
O	O	O	841	846	other	other	B-NP	JJ	O	22	NMOD	O
T26	B-Entity	B-Entity	847	856	monocytic	monocytic	I-NP	JJ	B-DNA	22	NMOD	B-DNA
T26	I-Entity	I-Entity	857	862	genes	gene	I-NP	NNS	I-DNA	19	PMOD	I-DNA
O	O	O	863	864	(	(	O	(	O	47	DEP	O
T9	B-Protein	B-Protein	864	867	TNF	TNF	B-NP	NN	B-protein	33	NMOD	B-protein
T9	I-Protein	I-Protein	867	868	-	-	O	HYPH	O	33	P	O
T9	I-Protein	I-Protein	868	873	alpha	alpha	B-NP	SYM	O	33	NMOD	O
O	O	O	873	874	,	,	O	,	O	33	P	O
T10	B-Protein	B-Protein	875	877	IL	IL	B-NP	NN	B-protein	30	NMOD	B-protein
T10	I-Protein	I-Protein	877	878	-	-	I-NP	HYPH	I-protein	30	NMOD	I-protein
T10	I-Protein	I-Protein	878	883	1beta	1beta	I-NP	NN	I-protein	33	NMOD	I-protein
O	O	O	883	884	,	,	O	,	O	33	P	O
T11	B-Protein	B-Protein	885	887	IL	IL	B-NP	NN	B-protein	33	NMOD	B-protein
T11	I-Protein	I-Protein	887	888	-	-	O	HYPH	I-protein	46	NMOD	I-protein
T11	I-Protein	I-Protein	888	889	6	6	B-NP	CD	I-protein	33	NMOD	I-protein
O	O	O	889	890	,	,	O	,	O	33	P	O
T12	B-Protein	B-Protein	891	893	IL	IL	B-NP	NN	B-protein	37	NMOD	B-protein
T12	I-Protein	I-Protein	893	894	-	-	O	HYPH	I-protein	33	VMOD	I-protein
T12	I-Protein	I-Protein	894	895	8	8	B-NP	CD	I-protein	37	NMOD	I-protein
O	O	O	895	896	,	,	O	,	O	45	P	O
T13	B-Protein	B-Protein	897	899	IL	IL	B-NP	NN	B-protein	41	NMOD	B-protein
T13	I-Protein	I-Protein	899	900	-	-	I-NP	HYPH	I-protein	45	NMOD	I-protein
T13	I-Protein	I-Protein	900	902	10	10	I-NP	CD	I-protein	41	NMOD	I-protein
O	O	O	902	903	,	,	O	,	O	45	P	O
T14	B-Protein	B-Protein	904	908	ICAM	ICAM	B-NP	NN	B-protein	45	NMOD	B-protein
T14	I-Protein	I-Protein	908	909	-	-	B-NP	HYPH	O	46	P	O
T14	I-Protein	I-Protein	909	910	1	1	I-NP	CD	O	47	DEP	O
O	O	O	910	911	)	)	O	)	O	22	NMOD	O
O	O	O	912	921	activated	activate	B-VP	VBN	O	22	NMOD	O
O	O	O	922	924	by	by	B-PP	IN	O	48	VMOD	O
O	O	O	925	933	exposure	exposure	B-NP	NN	O	49	PMOD	O
O	O	O	934	936	to	to	B-PP	TO	O	50	NMOD	O
O	O	O	937	938	a	a	B-NP	DT	O	56	NMOD	O
O	O	O	939	942	pro	pro	I-NP	AFX	B-DNA	56	NMOD	B-DNA
O	O	O	942	943	-	-	I-NP	HYPH	O	56	NMOD	O
O	O	O	943	955	inflammatory	inflammatory	I-NP	JJ	O	56	NMOD	O
O	O	O	956	964	stimulus	stimulus	I-NP	NN	O	51	PMOD	O
O	O	O	965	966	(	(	O	(	O	61	DEP	O
O	O	O	966	984	lipopolysaccharide	lipopolysaccharide	B-NP	NN	O	60	NMOD	O
O	O	O	984	985	,	,	O	,	O	60	P	O
O	O	O	986	989	LPS	LPS	B-NP	NN	O	61	DEP	O
O	O	O	989	990	)	)	O	)	O	56	NMOD	O
O	O	O	990	991	.	.	O	.	O	16	P	O

O	O	O	992	994	At	At	B-ADVP	IN	O	12	VMOD	O
O	O	O	995	1000	least	least	I-ADVP	JJS	O	1	AMOD	O
O	O	O	1001	1003	in	in	B-PP	IN	O	1	PMOD	O
O	O	O	1004	1007	the	the	B-NP	DT	O	5	NMOD	O
O	O	O	1008	1012	case	case	I-NP	NN	O	3	PMOD	O
O	O	O	1013	1015	of	of	B-PP	IN	O	5	NMOD	O
O	O	O	1016	1019	the	the	B-NP	DT	O	9	NMOD	O
T15	B-Protein	B-Protein	1020	1024	IL1B	IL1B	I-NP	NN	B-DNA	9	NMOD	B-DNA
T27	B-Entity	B-Entity	1025	1033	promoter	promoter	I-NP	NN	I-DNA	6	PMOD	I-DNA
O	O	O	1033	1034	,	,	O	,	O	12	P	O
O	O	O	1035	1045	repression	repression	B-NP	NN	O	12	SUB	O
O	O	O	1046	1049	did	do	B-VP	VBD	O	37	VMOD	O
O	O	O	1050	1053	not	not	I-VP	RB	O	12	VMOD	O
O	O	O	1054	1058	seem	seem	I-VP	VB	O	12	VC	O
O	O	O	1059	1061	to	to	I-VP	TO	O	16	VMOD	O
O	O	O	1062	1069	involve	involve	I-VP	VB	O	14	VMOD	O
O	O	O	1070	1077	another	another	B-NP	DT	O	18	NMOD	O
O	O	O	1078	1084	factor	factor	I-NP	NN	O	16	OBJ	O
O	O	O	1085	1090	whose	whose	B-NP	WP$	O	20	NMOD	O
O	O	O	1091	1099	activity	activity	I-NP	NN	O	18	NMOD	O
O	O	O	1100	1102	is	be	B-VP	VBZ	O	20	SBAR	O
O	O	O	1103	1111	affected	affect	I-VP	VBN	O	21	VC	O
O	O	O	1112	1114	by	by	B-PP	IN	O	22	VMOD	O
O	O	O	1115	1118	the	the	B-NP	DT	O	25	NMOD	O
O	O	O	1119	1125	NSAIDs	NSAID	I-NP	NNS	O	23	PMOD	O
O	O	O	1125	1126	,	,	O	,	O	37	P	O
T28	B-Entity	B-Entity	1127	1135	NFkappaB	NFkappaB	B-NP	NN	B-protein	37	SUB	B-protein
O	O	O	1136	1138	as	as	B-PP	IN	O	27	NMOD	O
O	O	O	1139	1142	the	the	B-NP	DT	O	32	NMOD	O
T16	B-Protein	B-Protein	1143	1147	IL1B	IL1B	I-NP	NN	B-DNA	32	NMOD	B-DNA
T29	B-Entity	B-Entity	1148	1156	promoter	promoter	I-NP	NN	I-DNA	32	NMOD	I-DNA
O	O	O	1157	1165	fragment	fragment	I-NP	NN	I-DNA	28	PMOD	I-DNA
O	O	O	1166	1170	used	use	B-VP	VBN	O	27	NMOD	O
O	O	O	1171	1173	in	in	B-PP	IN	O	33	VMOD	O
O	O	O	1174	1177	our	our	B-NP	PRP$	O	36	NMOD	O
O	O	O	1178	1185	studies	study	I-NP	NNS	O	34	PMOD	O
O	O	O	1186	1188	is	be	B-VP	VBZ	O	0	ROOT	O
O	O	O	1189	1192	not	not	O	RB	O	37	VMOD	O
T30	B-Entity	B-Entity	1193	1201	NFkappaB	NFkappaB	B-NP	NN	B-protein	37	PRD	B-protein
O	O	O	1202	1212	responsive	responsive	I-NP	JJ	O	39	AMOD	O
O	O	O	1213	1216	and	and	O	CC	O	37	VMOD	O
O	O	O	1217	1222	binds	bind	B-VP	VBZ	O	37	VMOD	O
O	O	O	1223	1235	specifically	specifically	B-ADVP	RB	O	42	VMOD	O
O	O	O	1236	1238	to	to	B-PP	TO	O	42	VMOD	O
T17	B-Protein	B-Protein	1239	1243	HSF1	HSF1	B-NP	NN	B-protein	44	PMOD	B-protein
O	O	O	1243	1244	.	.	O	.	O	37	P	O

O	O	O	1245	1253	Exposure	Exposure	B-NP	NN	O	4	SUB	O
O	O	O	1254	1256	to	to	B-PP	TO	O	1	NMOD	O
O	O	O	1257	1263	NSAIDs	NSAID	B-NP	NNS	O	2	PMOD	O
O	O	O	1264	1267	had	have	B-VP	VBD	O	0	ROOT	O
O	O	O	1268	1269	a	a	B-NP	DT	O	7	NMOD	O
O	O	O	1270	1277	complex	complex	I-NP	JJ	O	7	NMOD	O
O	O	O	1278	1284	effect	effect	I-NP	NN	O	4	OBJ	O
O	O	O	1285	1287	on	on	B-PP	IN	O	7	NMOD	O
T31	B-Entity	B-Entity	1288	1291	HSP	HSP	B-NP	NN	B-DNA	11	NMOD	B-DNA
T31	I-Entity	I-Entity	1292	1296	gene	gene	I-NP	NN	I-DNA	11	NMOD	I-DNA
O	O	O	1297	1307	expression	expression	I-NP	NN	O	8	PMOD	O
O	O	O	1308	1311	and	and	O	CC	O	4	VMOD	O
O	O	O	1312	1317	while	while	B-SBAR	IN	O	4	VMOD	O
O	O	O	1318	1326	sulindac	sulindac	B-NP	NN	O	15	SUB	O
O	O	O	1327	1336	activated	activate	B-VP	VBD	O	24	VMOD	O
O	O	O	1337	1340	the	the	B-NP	DT	O	20	NMOD	O
T32	B-Entity	B-Entity	1341	1347	stress	stress	I-NP	NN	O	20	NMOD	O
T32	I-Entity	I-Entity	1348	1358	responsive	responsive	I-NP	JJ	O	20	NMOD	O
T18,T32	B-Protein,I-Entity	B-Protein,I-Entity	1359	1365	HSP70B	HSP70B	I-NP	NN	B-DNA	20	NMOD	B-DNA
T32,T33	I-Entity,B-Entity	I-Entity,B-Entity	1366	1374	promoter	promoter	I-NP	NN	I-DNA	15	OBJ	I-DNA
O	O	O	1374	1375	,	,	O	,	O	24	P	O
O	O	O	1376	1382	sodium	sodium	B-NP	NN	O	23	NMOD	O
O	O	O	1383	1393	salicylate	salicylate	I-NP	NN	O	24	SUB	O
O	O	O	1394	1397	did	do	B-VP	VBD	O	13	SBAR	O
O	O	O	1398	1401	not	not	O	RB	O	24	VMOD	O
O	O	O	1401	1402	.	.	O	.	O	4	P	O

O	O	O	1403	1405	In	In	B-PP	IN	O	10	VMOD	O
O	O	O	1406	1414	addition	addition	B-NP	NN	O	1	PMOD	O
O	O	O	1414	1415	,	,	O	,	O	10	P	O
O	O	O	1416	1420	only	only	B-NP	RB	O	6	NMOD	O
O	O	O	1421	1422	a	a	I-NP	DT	O	6	NMOD	O
O	O	O	1423	1429	subset	subset	I-NP	NN	O	10	SUB	O
O	O	O	1430	1432	of	of	B-PP	IN	O	6	NMOD	O
O	O	O	1433	1436	the	the	B-NP	DT	O	9	NMOD	O
O	O	O	1437	1443	NSAIDs	NSAID	I-NP	NNS	O	7	PMOD	O
O	O	O	1444	1451	induced	induce	B-VP	VBD	O	0	ROOT	O
T19	B-Protein	B-Protein	1452	1457	HSP70	HSP70	B-NP	NN	B-RNA	13	NMOD	B-RNA
O	O	O	1458	1462	mRNA	mRNA	I-NP	NN	I-RNA	13	NMOD	I-RNA
O	O	O	1463	1470	species	specie	I-NP	NNS	I-RNA	10	OBJ	I-RNA
O	O	O	1470	1471	.	.	O	.	O	10	P	O

O	O	O	1472	1477	These	These	B-NP	DT	O	2	NMOD	O
O	O	O	1478	1486	findings	finding	I-NP	NNS	O	3	SUB	O
O	O	O	1487	1494	reflect	reflect	B-VP	VBP	O	0	ROOT	O
O	O	O	1495	1498	the	the	B-NP	DT	O	5	NMOD	O
O	O	O	1499	1509	properties	property	I-NP	NNS	O	3	OBJ	O
O	O	O	1510	1512	of	of	B-PP	IN	O	5	NMOD	O
T20	B-Protein	B-Protein	1513	1517	HSF1	HSF1	B-NP	NN	B-protein	6	PMOD	B-protein
O	O	O	1518	1523	which	which	B-NP	WDT	O	7	NMOD	O
O	O	O	1524	1527	can	can	B-VP	MD	O	8	SBAR	O
O	O	O	1528	1530	be	be	I-VP	VB	O	9	VC	O
O	O	O	1531	1540	activated	activate	I-VP	VBN	O	10	VC	O
O	O	O	1541	1543	to	to	B-PP	TO	O	11	VMOD	O
O	O	O	1544	1546	at	at	B-NP	IN	O	18	NMOD	O
O	O	O	1547	1552	least	least	I-NP	JJS	O	13	AMOD	O
O	O	O	1553	1556	two	two	I-NP	CD	O	13	AMOD	O
T34	B-Entity	B-Entity	1557	1560	DNA	DNA	I-NP	NN	B-protein	18	NMOD	B-protein
O	O	O	1561	1568	binding	binding	I-NP	NN	I-protein	18	NMOD	I-protein
O	O	O	1569	1574	forms	form	I-NP	NNS	I-protein	12	PMOD	I-protein
O	O	O	1575	1579	only	only	B-NP	RB	O	20	NMOD	O
O	O	O	1580	1583	one	one	I-NP	CD	O	21	NMOD	O
O	O	O	1584	1586	of	of	B-PP	IN	O	18	NMOD	O
O	O	O	1587	1592	which	which	B-NP	WDT	O	21	PMOD	O
O	O	O	1593	1602	activates	activate	B-VP	VBZ	O	21	SBAR	O
T35	B-Entity	B-Entity	1603	1607	heat	heat	B-NP	NN	B-DNA	26	NMOD	B-DNA
T35	I-Entity	I-Entity	1608	1613	shock	shock	I-NP	NN	I-DNA	26	NMOD	I-DNA
T35	I-Entity	I-Entity	1614	1623	promoters	promoter	I-NP	NNS	I-DNA	23	OBJ	I-DNA
O	O	O	1624	1627	and	and	O	CC	O	3	VMOD	O
O	O	O	1628	1635	suggest	suggest	B-VP	VBP	O	3	VMOD	O
O	O	O	1636	1640	that	that	B-SBAR	IN	O	28	VMOD	O
O	O	O	1641	1651	individual	individual	B-NP	JJ	O	33	NMOD	O
O	O	O	1652	1657	NSAID	NSAID	I-NP	NN	B-protein	33	NMOD	B-protein
O	O	O	1658	1664	family	family	I-NP	NN	I-protein	33	NMOD	I-protein
O	O	O	1665	1672	members	member	I-NP	NNS	I-protein	34	SUB	I-protein
O	O	O	1673	1676	may	may	B-VP	MD	O	29	SBAR	O
O	O	O	1677	1691	differentially	differentially	I-VP	RB	O	34	VMOD	O
O	O	O	1692	1698	induce	induce	I-VP	VB	O	34	VC	O
O	O	O	1699	1702	one	one	B-NP	CD	O	39	NMOD	O
O	O	O	1703	1705	or	or	O	CC	O	39	NMOD	O
O	O	O	1706	1711	other	other	B-ADJP	JJ	O	36	OBJ	O
O	O	O	1712	1714	of	of	B-PP	IN	O	39	NMOD	O
O	O	O	1715	1720	these	these	B-NP	DT	O	42	NMOD	O
O	O	O	1721	1726	forms	form	I-NP	NNS	O	40	PMOD	O
O	O	O	1726	1727	.	.	O	.	O	3	P	O

O	O	O	1728	1735	Overall	Overall	B-ADVP	RB	O	7	VMOD	O
O	O	O	1736	1745	therefore	therefore	I-ADVP	RB	O	1	AMOD	O
O	O	O	1745	1746	,	,	O	,	O	7	P	O
O	O	O	1747	1755	exposure	exposure	B-NP	NN	O	7	SUB	O
O	O	O	1756	1758	to	to	B-PP	TO	O	4	NMOD	O
O	O	O	1759	1765	NSAIDs	NSAID	B-NP	NNS	O	5	PMOD	O
O	O	O	1766	1771	leads	lead	B-VP	VBZ	O	0	ROOT	O
O	O	O	1772	1774	to	to	B-PP	TO	O	7	VMOD	O
O	O	O	1775	1776	a	a	B-NP	DT	O	11	NMOD	O
O	O	O	1777	1785	profound	profound	I-NP	JJ	O	11	NMOD	O
O	O	O	1786	1792	switch	switch	I-NP	NN	O	8	PMOD	O
O	O	O	1793	1795	in	in	B-PP	IN	O	11	NMOD	O
O	O	O	1796	1800	gene	gene	B-NP	NN	O	14	NMOD	O
O	O	O	1801	1811	expression	expression	I-NP	NN	O	12	PMOD	O
O	O	O	1812	1814	in	in	B-PP	IN	O	14	NMOD	O
O	O	O	1815	1824	monocytic	monocytic	B-NP	JJ	B-cell_type	17	NMOD	B-cell_type
O	O	O	1825	1830	cells	cell	I-NP	NNS	I-cell_type	15	PMOD	I-cell_type
O	O	O	1830	1831	,	,	O	,	O	7	P	O
O	O	O	1832	1836	with	with	B-PP	IN	O	7	VMOD	O
O	O	O	1837	1848	suppression	suppression	B-NP	NN	O	28	NMOD	O
O	O	O	1849	1851	of	of	B-PP	IN	O	20	NMOD	O
T36	B-Entity	B-Entity	1852	1857	genes	gene	B-NP	NNS	B-DNA	21	PMOD	B-DNA
O	O	O	1858	1866	involved	involve	B-VP	VBN	O	22	NMOD	O
O	O	O	1867	1869	in	in	B-PP	IN	O	23	VMOD	O
O	O	O	1870	1880	macrophage	macrophage	B-NP	NN	O	26	NMOD	O
O	O	O	1881	1891	activation	activation	I-NP	NN	O	24	PMOD	O
O	O	O	1892	1895	and	and	O	CC	O	28	NMOD	O
O	O	O	1896	1905	induction	induction	B-NP	NN	O	33	NMOD	O
O	O	O	1906	1908	of	of	B-PP	IN	O	28	NMOD	O
T37	B-Entity	B-Entity	1909	1915	stress	stress	B-NP	NN	B-DNA	31	NMOD	B-DNA
T37	I-Entity	I-Entity	1916	1921	genes	gene	I-NP	NNS	I-DNA	29	PMOD	I-DNA
O	O	O	1922	1925	and	and	O	CC	O	33	NMOD	O
T21	B-Protein	B-Protein	1926	1930	HSF1	HSF1	B-NP	NN	B-protein	19	PMOD	B-protein
O	O	O	1931	1938	appears	appear	B-VP	VBZ	O	7	VMOD	O
O	O	O	1939	1941	to	to	I-VP	TO	O	36	VMOD	O
O	O	O	1942	1946	play	play	I-VP	VB	O	34	VMOD	O
O	O	O	1947	1948	a	a	B-NP	DT	O	39	NMOD	O
O	O	O	1949	1959	regulatory	regulatory	I-NP	JJ	O	39	NMOD	O
O	O	O	1960	1964	role	role	I-NP	NN	O	36	OBJ	O
O	O	O	1965	1967	in	in	B-PP	IN	O	36	VMOD	O
O	O	O	1968	1973	these	these	B-NP	DT	O	42	NMOD	O
O	O	O	1974	1981	effects	effect	I-NP	NNS	O	40	PMOD	O
O	O	O	1981	1982	.	.	O	.	O	7	P	O

O	O	O	1983	1992	Copyright	Copyright	B-NP	NN	O	4	NMOD	O
O	O	O	1993	1997	1999	1999	I-NP	CD	O	4	NMOD	O
O	O	O	1998	2006	Academic	Academic	I-NP	NNP	O	4	NMOD	O
O	O	O	2007	2012	Press	Press	I-NP	NNP	O	0	ROOT	O
O	O	O	2012	2013	.	.	O	.	O	4	P	O
